Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition

• US 7,761,147 B2
• Filed: 03/18/2005
• Issued: 07/20/2010
• Est. Priority Date: 04/04/2001
• Status: Expired due to Fees

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Young, Wendy A., Cormier, Michel J. N.
• Primary Examiner(s): Sirmons; Kevin C
• Assistant Examiner(s): OSINSKI, BRADLEY JAMES
• Application Number:
  US11/084,628
• Publication Number:
  US 20050187511A1
• Time in Patent Office: 1,950 Days
• Field of Search: 604 19- 21, 604/82, 604/115, 604/149, 604/152, 604/153, 604304-308, 604447-449, 604/890.1, 604/891.1
• US Class Current: 604/20
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: A61P 25/04 Centrally acting analgesics, e.g. opioids

Abstract

A transdermal electrotransport drug delivery device having an anode, a cathode and a source of electrical power electrically connected to the anode and the cathode. At least one of the anode and the cathode includes an electrode and a reservoir comprised of a housing composed of a polymeric material and an aqueous medium in contact with the housing. The aqueous medium includes (i) a drug or an electrolyte salt or a mixture thereof, (ii) propylene glycol, and (iii) an antimicrobial agent in an amount sufficient to inhibit microbial growth in the aqueous medium. The propylene glycol prevents the antimicrobial agent from being adsorbed by other materials used in the construction of the delivery device. A process for preparing a transdermal electrotransport drug delivery device is also provided.

Claims

1. A process for transdermally delivering a drug to or sampling a body analyte from a patient by electrotransport from an electrotransport device comprised of an anode, a cathode and a source of electrical power electrically connected to said anode and said cathode, at least one of said anode and said cathode including an electrode and a reservoir comprised of a housing, said housing comprised of a polymeric material and an aqueous medium in contact with said housing, said aqueous medium comprised of (i) a drug or an electrolyte salt, (ii) propylene glycol, and iii) an antimicrobial agent in an amount sufficient to inhibit microbial growth in said aqueous medium, wherein said propylene glycol is present in an amount that renders said antimicrobial agent compatible with said device, said process comprising:

providing electric current from said source of electrical power so that said drug is transdermally delivered to or said body analyte sampled from said patient by electrotransport from or to one of said reservoirs.

2. The process of claim 1, wherein said aqueous medium has a pH in the range of approximately 4.0 to 9.0.

3. The process of claim 1, wherein said aqueous medium has a pH in the range of approximately 5.0 to 8.0.

4. The process of claim 1, wherein said aqueous medium further comprises a buffer.

5. The process of claim 1, wherein said polymeric housing material is selected from the group consisting of polyethylene terephthalate, polyethylene terephthalate modified with cyclohexane dimethylol, polypropylene, polyethylene, polyethylene copolymers, and mixtures thereof.

6. The process of claim 1, wherein said cathodic reservoir contains an aqueous medium of an electrolyte salt and is substantially drug free.

7. The process of claim 1, wherein said anode includes an anodic electrode and an anodic reservoir containing a drug.

8. The process of claim 1, wherein the antimicrobial agent is selected from the group consisting of methylparaben, ethylparaben and propylparaben, propyl gallate, butylated hydroxyanisole (BRA) (BHA), butylated hydroxytoluene, t-butyl-hydroquinone, chloroxylenol, chlorohexidine, dichlorobenzyl alcohol, dehydroacetic acid, hexetidine and triclosan.

9. The process of claim 1, wherein said antimicrobial agent comprises a paraben.

10. The process of claim 1, wherein said antimicrobial agent is present in in the range of approximately 0.005% to 2% by weight of said aqueous medium.

11. The process of claim 10, wherein said antimicrobial agent is present in the range of approximately 0.01% to 1% by weight of said aqueous medium.

12. The process of claim 1, wherein said propylene glycol is present in the range of approximately 5% to 50% by weight of said aqueous medium.

13. The process of claim 12, wherein said propylene glycol is present in the range of approximately 5% to 30% by weight of the aqueous medium.

14. The process of claim 1, wherein said propylene glycol prevents migration of said antimicrobial agent into the material of said electrotransport device in an amount less than 0.25 mg of antimicrobial agent per gram of material.

15. The process of claim 14, wherein said propylene glycol prevents migration of said antimicrobial agent into the material of said electrotransport device in an amount less than 0.10 mg of antimicrobial agent per gram of material.

16. The process of claim 15, wherein said propylene glycol prevents migration of said antimicrobial agent into the material of said electrotransport device in an amount less than 0.025 mg of antimicrobial agent per gram of material.

17. The process of claim 1, wherein said antimicrobial agent is ionizable.

18. The process of claim 17, wherein said antimicrobial agent is selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, and chlorhexidine salts.

19. The process of claim 1, wherein said antimicrobial agent is not transdermally delivered to the patient.

20. The process of claim 1, wherein said drug is selected from the group consisting of fentanyl, sufentanil, and salts thereof.